Preventive care & Predictive Diagnostics

Life-threatening diseases like cancer & chronic diseases such as diabetes, hypertension, and congestive heart failure & obesity are impacting all age groups globally. With the advancement of genetic science and technologies capable of early diagnosis, innovation has caught up the speed to capture opportunities. Reimbursement agencies, payers & providers had inhibitions and doubts on the outcome and return on investment for these programs. However, a long-term outlook on the healthcare costs, quality of life, and wellbeing of society have convinced the payers to reimburse the preventive propositions.

FutureBridge is enabling companies with identification of opportunities in early diagnosis, the combination of artificial intelligence & gene editing for prevention and treatment of life-threatening disease segments.